Spectrum Library
-
A review of human diseases caused or exacerbated by aberrant complement activation.
-
Microarray Analysis of lncRNA and mRNA Expression Profiles in Patients with Neuromyelitis Optica.
-
Rituximab in Neuromyelitis Optica Spectrum Disorders-Reply: Why Not as First-Line Therapy.
-
Normal-appearing white matter demyelination in neuromyelitis optica spectrum disorder.
-
Optic Neuropathy Associated with Primary Sjรถgren’s Syndrome: A Case Series.
-
Neuromyelitis Spectrum Disorders.
-
Bell’s palsy in children: Current treatment patterns in Australia and New Zealand. A PREDICT study.
-
Large-Scale in-House Cell-Based Assay for Evaluating the Serostatus in Patients with Neuromyelitis Optica Spectrum Disorder Based on New Diagnostic Criteria.
-
Anti-NMDAR encephalitis followed by seropositive neuromyelitis optica spectrum disorder: A case report and literature review.
-
Elevated C-X-C motif ligand 13 and B-cell-activating factor levels in neuromyelitis optica during remission.
-
Efficacy and safety of tacrolimus treatment for neuromyelitis optica spectrum disorder.
-
Increased cerebrospinal fluid progranulin correlates with interleukin-6 in the acute phase of neuromyelitis optica spectrum disorder.